Fundz

Elixir Medical

Washington, District of Columbia, United States · Biotechnology, Health Care, Medical · 93 employees

Elixir Medical is a developer of disruptive technologies aimed at treating cardiovascular disease. The company focuses on innovative solutions like the DynamX Coronary Bioadaptor System, which has shown significant benefits over traditional drug-eluting stents. Their technologies aim to improve patient outcomes and reduce adverse event rates in high-risk populations. Elixir Medical is committed to

Recent signals

  • Oct 28, 2024: Launched Elixir Medical Launches the DynamX Coronary Bioadaptor System, Showcasing Significant Benefits in Patients with Acute Coronary Syndrome.

See plans & pricing → Track Elixir Medical’s funding, hiring, and signals — with verified contacts — on Fundz.